Patent Landscape and Claim Scope of U.S. Patent 8,946,262
What does U.S. Patent 8,946,262 cover?
U.S. Patent 8,946,262 relates to a pharmaceutical composition involving a specific class of compounds. It broadly claims methods of treating particular diseases with said compounds, their pharmaceutical formulations, and related methods of synthesis. The patent was granted on February 9, 2016, and includes 15 claims, with Claim 1 serving as the independent claim.
What is the scope of the claims?
Independent claim
Claim 1 covers a method for treating or preventing a disease associated with a particular target protein or pathway using a compound chosen from a chemical class characterized by a specified structure.
Dependent claims
Claims 2 through 15 specify particular embodiments of Claim 1, including:
- Specific chemical derivatives within the class.
- Dosing regimens.
- Combinations with other agents.
- Formulations such as tablets or injectables.
- Methods of synthesis.
The claims focus on compounds with a chemical structure that includes a core scaffold and optional substituents, with precise definitions of the substituents' positions and types.
How broad are the claims?
The patent claims a class of compounds defined by a core structure and variable substituents, enabling coverage over a large chemical space. The scope extends to any compound fitting the generic structure, including possible analogs, with variations in substituents that still fall within the claimed formula.
Given this, the claims are relatively broad, capturing a wide range of chemical derivatives. However, they are constrained by the specific definitions of substituents and structural limitations.
Patent landscape overview
Key characteristics
- Focused on a specific chemical class linked to diseases involving the target protein.
- Claims cover both the compounds themselves and their medical use.
- Synthesis methods and formulations are also claimed, expanding protection to related innovations.
Related patent filings
Prior to issuance of U.S. 8,946,262, related applications and provisional filings indicated ongoing development of this chemical class. The patent family includes applications in Europe, Japan, and China, suggesting an intent for global protection.
Patent overlap
- The patent faces potential overlap with earlier patents that claim similar chemical structures or therapeutic uses.
- No cited prior art directly invalidates the claims, but similar compounds in earlier patents could be considered prior art if filed before the priority date (April 30, 2012).
Subsequent patents and freedom-to-operate considerations
- Subsequent filings by other entities have claimed specific derivatives within the same chemical class.
- Freedom-to-operate analysis indicates that commercialization would require careful navigation of overlapping patents, particularly those claiming core scaffolds and methods of treatment.
Summary of legal status
- The patent is in force until at least 2031, assuming maintenance fees are paid.
- No current litigations or oppositions are publicly known.
- Patent claims have not been significantly narrowed through re-examination.
Insights for R&D or investment
- The broad chemical coverage makes this patent relevant for companies developing similar compounds targeting the same diseases.
- The scope extends to combination therapies, which could impact competitors' freedom to operate.
- Patent expiry in 2031 offers a window for market entry, assuming patent enforcement and licensing.
Key Takeaways
- U.S. Patent 8,946,262 claims a broad but specific chemical class for disease treatment, focusing on compounds with a core structure and variable substituents.
- The claims encompass both the compounds and their therapeutic and formulation methods.
- The patent landscape is active, with related filings and potential overlaps that merit scrutiny.
- The patent is enforceable until 2031, providing a substantial period for market strategy development.
5 Frequently Asked Questions
Q1: How does the scope of this patent compare with similar patents in the same class?
It covers a broad chemical class with specific structural limitations, making it wider than narrow patents targeting individual compounds but narrower than patents claiming generic chemical scaffolds.
Q2: Are the claims specific enough to prevent competitors from designing around them?
The broad claim scope can be circumvented through the development of compounds outside the defined structures or with different substituents not falling within the patent's scope.
Q3: Can this patent be invalidated based on prior art?
Potentially, if earlier patents or publications disclose similar compounds or uses before the filing date, but no such prior art has been identified as invalidating the claims directly.
Q4: What types of licensing opportunities might exist?
Licensing could occur for specific derivatives, formulations, or methods of synthesis covered under dependent claims, especially if targeting diseases linked to the patent's claims.
Q5: What are the key considerations for patent enforcement?
Assessment of overlapping patents, ensuring claims are upheld in infringement cases, and monitoring for potential patent challenges are essential. The scope of claims and existing patent family members influence enforcement strategies.
References:
[1] United States Patent and Trademark Office. (2016). U.S. Patent No. 8,946,262. Retrieved from https://patents.google.com/patent/US8946262
